Innoviva Inc (INVA)
14.93
-0.02
(-0.13%)
USD |
NASDAQ |
Apr 22, 16:00
14.95
+0.02
(+0.13%)
After-Hours: 20:00
Innoviva Cash from Investing (TTM): -66.76M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -66.76M |
September 30, 2023 | -70.29M |
June 30, 2023 | 53.32M |
March 31, 2023 | 50.80M |
December 31, 2022 | -56.63M |
September 30, 2022 | -67.86M |
June 30, 2022 | -165.58M |
March 31, 2022 | -73.04M |
December 31, 2021 | 43.72M |
September 30, 2021 | -251.85M |
June 30, 2021 | -260.35M |
March 31, 2021 | -357.38M |
December 31, 2020 | -314.94M |
September 30, 2020 | 52.54M |
June 30, 2020 | 45.10M |
March 31, 2020 | 72.21M |
December 31, 2019 | -18.00M |
September 30, 2019 | -115.59M |
June 30, 2019 | -86.13M |
March 31, 2019 | -97.16M |
December 31, 2018 | 3.519M |
September 30, 2018 | 23.23M |
June 30, 2018 | -12.06M |
March 31, 2018 | -19.12M |
December 31, 2017 | -23.24M |
Date | Value |
---|---|
September 30, 2017 | 25.96M |
June 30, 2017 | 32.64M |
March 31, 2017 | 6.122M |
December 31, 2016 | -4.58M |
September 30, 2016 | 71.39M |
June 30, 2016 | 38.61M |
March 31, 2016 | 97.15M |
December 31, 2015 | 159.17M |
September 30, 2015 | 51.47M |
June 30, 2015 | 39.80M |
March 31, 2015 | -5.48M |
December 31, 2014 | -65.06M |
September 30, 2014 | -58.08M |
June 30, 2014 | -98.14M |
March 31, 2014 | -160.44M |
December 31, 2013 | -219.58M |
September 30, 2013 | -218.01M |
June 30, 2013 | -152.11M |
March 31, 2013 | -111.68M |
December 31, 2012 | -58.28M |
September 30, 2012 | -53.88M |
June 30, 2012 | -30.07M |
March 31, 2012 | -46.20M |
December 31, 2011 | -55.82M |
September 30, 2011 | -78.40M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-357.38M
Minimum
Mar 2021
72.21M
Maximum
Mar 2020
-83.51M
Average
-67.86M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Oragenics Inc | -0.9363M |